SCHEMBL3789480

SCHEMBL3789480

CCCc1cc(N)ccc1B(O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.43
ACHE P22303 3/20 0.42
LIPG Q9Y5X9 4/20 0.39
LPL P06858 3/20 0.39
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ENPP2 Q13822 1/20 0.36
GAA P10253 2/20 0.34
MAPT P10636 2/20 0.34
CASP1 P29466 2/20 0.34
HTT P42858 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
CASP7 P55210 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
TSHR P16473 2/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3785162 0.89 LIPG (0.49) PRKCIACHELIPGLPLMAPT
SCHEMBL3790140 0.86 LIPG (0.42) PRKCIACHELIPGLPLALDH1A1
SCHEMBL3790660 0.86 PRKCI (0.44) PRKCIACHELIPGLPLALDH1A1
SCHEMBL3790270 0.82 PRKCI (0.40) PRKCIACHELIPGALDH1A1KDM4E
SCHEMBL27298776 0.80 HPGD (0.50) ALDH1A1GAAMAPTCASP1MEN1
SCHEMBL4576433 0.79 PRKCI (0.44) PRKCIACHEALDH1A1KDM4EGAA
SCHEMBL23088815 0.78 PRKCI (0.46) PRKCIACHEALDH1A1KDM4EENPP2
SCHEMBL5381058 0.78 PRKCI (0.63) PRKCIACHEALDH1A1KDM4ECASP1
Alcohol SCHEMBL28761735 0.78 PRKCI (0.44) PRKCIACHEALDH1A1KDM4EGAA
SCHEMBL146162 0.77 PRKCI (0.42) PRKCIACHEALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 PRKCI 4454/4885ACHE 295/4885LIPG 3010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.